Mgr. David Potěšil, Ph.D.
Deputy Core Facility Leader, Proteomics Core Facility
Office: bldg. E26/107b
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 8426 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 207
2010
-
Srovnávací proteomická analýza myelomových buněk metodami SDS-PAGE/LC-MS/MS a 2-DE
Year: 2010, type: Conference abstract
-
Stanovení intracelulární koncentrace imatinibu u CML pacientů
Year: 2010, type: Conference abstract
2009
-
Biomarker discovery - Detection of minor protein concentration changes using ICPL protein labeling and 2D GE
Year: 2009, type: R&D Presentation
-
Monoclonal antibody rituximab sensitizes a proportion of CLL samples to fludarabine - searching for responsible genes
Year: 2009, type: Conference abstract
-
Presence of heterozygous ATM deletion may not be critical in the primary response of chronic lymphocytic leukemia cells to fludarabine
European Journal of Haematology, year: 2009, volume: 82, edition: 2, DOI
-
Sensitization of leukemic cells to fludarabine by monoclonal antibody rituximab - identification of responsible genes
Year: 2009, type: Conference abstract
-
Senzitivizace CLL buněk na fludarabin monoklonální protilátkou rituximab - identifikace zodpovědných genů
Year: 2009, type: Conference abstract
2008
-
Heterozygotní delece ATM nezvyšuje rezistenci CLL buněk na fludarabin
Year: 2008, type: Conference abstract
-
Presence of heterozygous ATM deletion may not be critical for the response of CLL cells to fludarabine
Year: 2008, type: Conference abstract
-
Přítomnost heterozygotní delece ATM nedeterminuje odpověď CLL buněk na fludarabin
Year: 2008, type: Conference abstract